James B. West

Person

Bend, OR, US

People

Patents Grantslast 30 patents

Information Patent Grant
Protease-resistant systems for polypeptide display and methods of m...
- Patent number 12,139,816
- Issue date Nov 12, 2024
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Anti-CD40 antibodies and uses thereof
- Patent number 11,952,427
- Issue date Apr 9, 2024
- Bristol-Myers Squibb Company
- Bryan C. Barnhart
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Activatable antibodies that bind epidermal growth factor receptor a...
- Patent number 11,890,354
- Issue date Feb 6, 2024
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- G01 - MEASURING TESTING
Information Patent Grant
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...
- Patent number 11,753,466
- Issue date Sep 12, 2023
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,548,944
- Issue date Jan 10, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,548,943
- Issue date Jan 10, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,472,875
- Issue date Oct 18, 2022
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD40 antibodies and uses thereof
- Patent number 11,306,149
- Issue date Apr 19, 2022
- Bristol-Myers Squibb Company
- Bryan C. Barnhart
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Protease-resistant systems for polypeptide display and methods of m...
- Patent number 11,198,864
- Issue date Dec 14, 2021
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...
- Patent number 11,174,316
- Issue date Nov 16, 2021
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multispecific antibodies, multispecific activatable antibodies and...
- Patent number 11,161,906
- Issue date Nov 2, 2021
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable anti-CTLA-4 antibodies and uses thereof
- Patent number 11,117,968
- Issue date Sep 14, 2021
- Bristol-Myers Squibb Company
- Kimberly Ann Tipton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,046,759
- Issue date Jun 29, 2021
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for manufacturing activatable binding polypeptides comprisi...
- Patent number 11,028,162
- Issue date Jun 8, 2021
- The Regents of the University of California
- Patrick Sean Daugherty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protease-resistant systems for polypeptide display and methods of m...
- Patent number 10,947,531
- Issue date Mar 16, 2021
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Methods of treatment using activatable anti-EGFR antibodies
- Patent number 10,875,913
- Issue date Dec 29, 2020
- CytomX Therapeutics, Inc.
- Nancy Elizabeth Stagliano
- G01 - MEASURING TESTING
Information Patent Grant
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...
- Patent number 10,745,481
- Issue date Aug 18, 2020
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable antibodies that bind epidermal growth factor receptor a...
- Patent number 10,709,799
- Issue date Jul 14, 2020
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...
- Patent number 10,669,339
- Issue date Jun 2, 2020
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable antibodies that bind interleukin-6 receptor and methods...
- Patent number 10,611,845
- Issue date Apr 7, 2020
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...
- Patent number 10,577,420
- Issue date Mar 3, 2020
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-PD1 antibodies, activatable anti-PD1 antibodies, and methods o...
- Patent number 10,513,558
- Issue date Dec 24, 2019
- CytomX Therapeutics, Inc.
- Kimberly Ann Tipton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cleavage-activatable interferon-alpha proprotein
- Patent number 10,513,549
- Issue date Dec 24, 2019
- CytomX Therapeutics, Inc.
- Nancy E. Stagliano
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...
- Patent number 10,336,824
- Issue date Jul 2, 2019
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-...
- Patent number 10,301,380
- Issue date May 28, 2019
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified antibody containing the cleavable peptide with the amino a...
- Patent number 10,118,961
- Issue date Nov 6, 2018
- CytomX Therapeutics, Inc.
- Nancy E. Stagliano
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable binding polypeptides and methods of identification and...
- Patent number 10,077,300
- Issue date Sep 18, 2018
- The Regents of the University of California
- Patrick Sean Daugherty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-EGFR activatable antibodies
- Patent number 10,059,762
- Issue date Aug 28, 2018
- CytomX Therapeutics, Inc.
- Nancy Elizabeth Stagliano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating CD155 expressing cancers
- Patent number 9,994,637
- Issue date Jun 12, 2018
- Bristol-Myers Squibb Company
- Zeren Gao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable antibodies that bind epidermal growth factor receptor a...
- Patent number 9,889,211
- Issue date Feb 13, 2018
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...
- Publication number 20240398998
- Publication date Dec 5, 2024
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- G01 - MEASURING TESTING
Information Patent Application
MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF
- Publication number 20240228603
- Publication date Jul 11, 2024
- CytomX Therapeutics, Inc.
- Nancy Elizabeth Stagliano
- G01 - MEASURING TESTING
Information Patent Application
ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...
- Publication number 20240076374
- Publication date Mar 7, 2024
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20230212283
- Publication date Jul 6, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROPROTEINS AND METHODS OF USE THEREOF
- Publication number 20230183308
- Publication date Jun 15, 2023
- CytomX Therapeutics, Inc.
- Nancy E. Stagliano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROPROTEINS AND METHODS OF USE THEREOF
- Publication number 20230035290
- Publication date Feb 2, 2023
- CytomX Therapeutics, Inc.
- Nancy E. Stagliano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20230021301
- Publication date Jan 19, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20220380453
- Publication date Dec 1, 2022
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD40 ANTIBODIES AND USES THEREOF
- Publication number 20220324989
- Publication date Oct 13, 2022
- Bristol-Myers Squibb Company
- Bryan C. BARNHART
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...
- Publication number 20220298245
- Publication date Sep 22, 2022
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF M...
- Publication number 20220235351
- Publication date Jul 28, 2022
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Activatable Binding Polypeptides and Methods of Identification and...
- Publication number 20220098294
- Publication date Mar 31, 2022
- The Regents of the University of California
- Patrick Sean Daugherty
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Activatable Anti-CTLA-4 Antibodies and Uses Thereof
- Publication number 20220089734
- Publication date Mar 24, 2022
- Bristol-Myers Squibb Company
- Kimberly Ann TIPTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
- Publication number 20220002419
- Publication date Jan 6, 2022
- ZymoGenetics, Inc.
- Zeren GAO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20210355208
- Publication date Nov 18, 2021
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20210347886
- Publication date Nov 11, 2021
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF
- Publication number 20210284721
- Publication date Sep 16, 2021
- CytomX Therapeutics, Inc.
- Nancy Elizabeth Stagliano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND...
- Publication number 20210238291
- Publication date Aug 5, 2021
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PD-1 ANTIBODIES, ACTIVATABLE ANTI-PD-1 ANTIBODIES, AND METHODS...
- Publication number 20210179713
- Publication date Jun 17, 2021
- CytomX Therapeutics, Inc.
- Kimberly Ann Tipton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...
- Publication number 20210023243
- Publication date Jan 28, 2021
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- G01 - MEASURING TESTING
Information Patent Application
ANTI-CD40 ANTIBODIES AND USES THEREOF
- Publication number 20200339700
- Publication date Oct 29, 2020
- Bristol-Myers Squibb Company
- Bryan C. BARNHART
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ACTIVATABLE ANTIBODIES THAT BIND INTERLEUKIN-6 RECEPTOR AND METHODS...
- Publication number 20200339694
- Publication date Oct 29, 2020
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF M...
- Publication number 20200339976
- Publication date Oct 29, 2020
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROPROTEINS AND METHODS OF USE THEREOF
- Publication number 20200308243
- Publication date Oct 1, 2020
- CytomX Therapeutics, Inc.
- Nancy E. Stagliano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...
- Publication number 20200291113
- Publication date Sep 17, 2020
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...
- Publication number 20200231677
- Publication date Jul 23, 2020
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...
- Publication number 20190382493
- Publication date Dec 19, 2019
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
- Publication number 20190375843
- Publication date Dec 12, 2019
- ZymoGenetics, Inc.
- Zeren GAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-JAGGED 1/JAGGED 2 CROSS-REACTIVE ANTIBODIES, ACTIVATABLE ANTI-...
- Publication number 20190367589
- Publication date Dec 5, 2019
- CytomX Therapeutics, Inc.
- James William WEST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Activatable Anti-CTLA-4 Antibodies and Uses Thereof
- Publication number 20190359714
- Publication date Nov 28, 2019
- Bristol-Myers Squibb Company
- Kimberly Ann TIPTON
- C07 - ORGANIC CHEMISTRY

James B. West

Person

Patents Grantslast 30 patents

Protease-resistant systems for polypeptide display and methods of m...

Anti-CD40 antibodies and uses thereof

Activatable antibodies that bind epidermal growth factor receptor a...

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Anti-CD40 antibodies and uses thereof

Protease-resistant systems for polypeptide display and methods of m...

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...

Multispecific antibodies, multispecific activatable antibodies and...

Activatable anti-CTLA-4 antibodies and uses thereof

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Methods for manufacturing activatable binding polypeptides comprisi...

Protease-resistant systems for polypeptide display and methods of m...

Methods of treatment using activatable anti-EGFR antibodies

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...

Activatable antibodies that bind epidermal growth factor receptor a...

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...

Activatable antibodies that bind interleukin-6 receptor and methods...

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...

Anti-PD1 antibodies, activatable anti-PD1 antibodies, and methods o...

Cleavage-activatable interferon-alpha proprotein

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-...

Modified antibody containing the cleavable peptide with the amino a...

Activatable binding polypeptides and methods of identification and...

Anti-EGFR activatable antibodies

Method of treating CD155 expressing cancers

Activatable antibodies that bind epidermal growth factor receptor a...

Patents Applicationslast 30 patents

ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...

MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF

ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

PROPROTEINS AND METHODS OF USE THEREOF

PROPROTEINS AND METHODS OF USE THEREOF

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

ANTI-CD40 ANTIBODIES AND USES THEREOF

ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...

PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF M...

Activatable Binding Polypeptides and Methods of Identification and...

Activatable Anti-CTLA-4 Antibodies and Uses Thereof

COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF

MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND...

ANTI-PD-1 ANTIBODIES, ACTIVATABLE ANTI-PD-1 ANTIBODIES, AND METHODS...

ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...

ANTI-CD40 ANTIBODIES AND USES THEREOF

ACTIVATABLE ANTIBODIES THAT BIND INTERLEUKIN-6 RECEPTOR AND METHODS...

PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF M...

PROPROTEINS AND METHODS OF USE THEREOF

ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...

ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...

ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...

COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES

ANTI-JAGGED 1/JAGGED 2 CROSS-REACTIVE ANTIBODIES, ACTIVATABLE ANTI-...

Activatable Anti-CTLA-4 Antibodies and Uses Thereof